Company profile
Glow Lifetech Corp.
OTC: GLWLF · Healthcare · Biotechnology
Canadian filerHQ Toronto, ONReports USD
#833 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH 61DQ —GM —SS 25
v0.1 · 35/100 weight · pillars only
↑ revenue growth (YoY), balance-sheet leverage · ↓ listing tenure, workforce scale
Methodology →Revenue TTM
$1.7M
Rev growth YoY (TTM)
+61.5%
Net income (FY)
-$441.6k
Employees
5
as of 2026-08-23
Market cap
$6.9M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.5M2.1M CAD2025
Net income-$441.6k-617.4k CAD2025
Operating income-$520.2k-727.2k CAD2025
Total assets$2.9M3.9M CAD2025
Liabilities$879.8k1.2M CAD2025
Equity$2.0M2.7M CAD2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Glow Lifetech Corp.’s revenue?
Glow Lifetech Corp. booked $1.5M in FY2025 revenue, growing 140% year over year — faster than most Healthcare companies we track, at a -30.1% net margin.
Peers · Healthcare
St. Joseph, Inc.67BStatera Biopharma, Inc.——Xsovt Brands, Inc.——American Green, Inc.51DDaxor Corporation——Perspective Therapeutics, Inc.46DKey facts
CEORoberto Paolo Carducci
SectorHealthcare
IndustryBiotechnology
HeadquartersToronto, ON
ExchangeOTC: GLWLF
Employees5
IPO date2021-10-28
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.